Physician profile
Amanda Wallace
NPI 1174750707
$1,011.83
in general payments reported to CMS, 2019-2025
22 companies · $47.75 in 2025
The $47.75 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $113 · 2021: $154 · 2022: $27.91 · 2023: $155 · 2024: $59.41 · 2025: $47.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $204.61 | 2019 | |
| Indivior INC. | $128.76 | 2022-2025 | Sublocade |
| Spr Therapeutics, INC | $99.55 | 2019 | |
| Pfizer INC. | $95.62 | 2019-2023 | |
| Collegium Pharmaceutical, INC. | $65.80 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $58.43 | 2019-2021 | |
| Abbvie INC. | $52.92 | 2024-2025 | |
| Boston Scientific Corporation | $43.44 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Merz Pharmaceuticals, LLC | $42.71 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $24.43 | 2019-2020 | |
| Mdd US Operations, LLC | $24.21 | 2019 | |
| Grt US Holding, INC. | $22.58 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $22.05 | 2024 | Rexulti |
| Arbor Pharmaceuticals, INC. | $16.37 | 2021 | |
| Curonix LLC | $15.65 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15.50 | 2021 | |
| Amgen INC. | $14.53 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $14.30 | 2023 | Farxiga |
| Vertiflex, INC. | $14.07 | 2019 | |
| Idorsia Pharmaceuticals US INC | $12.89 | 2023 | Quviviq |
| Allergan, INC. | $12.06 | 2019 | |
| Scilex Pharmaceuticals INC. | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.